Celix Pharma announces the launch of Sitagliptin Tablets

27th Sep 2022

Celix Pharma is pleased to announce the launch of Sitagliptin 25mg, 50mg and 100mg film-coated tablets on loss of exclusivity in the UK. All 3 strengths are available in blister packs of 28 tablets. 

08th Sep 2022

Celix Pharma is pleased to announce the launch of Abiraterone 500 mg film-coated tablets in the UK. Abiraterone 500mg is available in unit-dose blister packs of 56 tablets. 

29th July 2022

Celix Pharma is delighted to announce the launch of Icatibant 30mg Solution for Injection in a pre-filled syringe. Icatibant is available in a pack of 1 syringe, with a separate needle. 

1st July 2022

Celix Pharma is excited to announce the launch of Pirfenidone 267mg, 801mg Film-coated Tablets in the UK.  The 267mg is available in blister packs of 63 and 252 tablets, whereas the 801mg is available in a blister pack of 84 tablets.  

18th May 2022 

Celix Pharma is excited to announce the launch of Fesoterodine fumarate 4mg, 8mg prolonged-release Tablets in the UK. Both strengths are available in blister (patient) packs of 28 tablets.

27th April 2022
Celix Pharma is pleased to announce the grant of its Marketing Authorisation (MA) for Icatibant 30mg Solution for Injection in a pre-filled syringe by the MHRA. 

14th February 2022
Celix Pharma is pleased to announce its partners’ approval of a Marketing Authorisation (MA) for Fesoterodine fumarate 4mg and 8mg prolonged-release tablets by the MHRA.

14th December 2021
Celix Pharma is pleased to announce the grant of its Marketing Authorisation (MA) for Abiraterone 500mg Film-coated tablets by the MHRA.   

5th November 2021
Celix Pharma is pleased to announce the grant of its first Marketing Authorisation (MA) for Pirfenidone 267mg, 534mg and 801mg Tablets by the MHRA.  

London,  21st  December 2020
Celix Pharma, a UK-based startup in the UK / EU generic pharmaceutical space, announced that it has raised GBP 2.5million in seed funding.